---
title: "Montega reiterates Buy on AlzChem, sets EUR 220 price target"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294387210.md"
description: "Montega reiterated a Buy rating on AlzChem with a EUR 220 price target. AlzChem reported Q2 revenue of EUR 155.3 million, up 8.7% YoY and beating estimates, while EBITDA rose 10.7% to EUR 32.2 million. The company maintained its full-year guidance at approximately EUR 600 million in revenue and EUR 126 million in EBITDA. Additionally, Montega highlighted progress in capacity expansion, including a nitroguanidine ramp-up in Germany starting in the second half."
datetime: "2026-07-30T15:18:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294387210.md)
  - [en](https://longbridge.com/en/news/294387210.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294387210.md)
---

# Montega reiterates Buy on AlzChem, sets EUR 220 price target

-   Montega reiterated a Buy rating on AlzChem, keeping its 12-month price target at EUR 220. \* Q2 revenue rose 8.7% year over year to EUR 155.3 million, beating Montega’s EUR 147 million estimate. \* Q2 EBITDA increased 10.7% to EUR 32.2 million, despite pressure in Basics & Intermediates. \* Guidance stayed unchanged at about EUR 600 million revenue, about EUR 126 million EBITDA. \* Montega flagged capacity expansion progress, including a nitroguanidine ramp-up in Germany starting in H2. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AlzChem Group AG published the original content used to generate this news brief via EQS News (Ref. ID: rc\_26340) on July 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ACT.DE](https://longbridge.com/en/quote/ACT.DE.md)
- [EQS.DE](https://longbridge.com/en/quote/EQS.DE.md)

## Related News & Research

- [AlzChem managing body member Andreas Niedermaier buys shares worth EUR 19,999.99](https://longbridge.com/en/news/294709319.md)
- [ACT: Strong H1 2026 growth driven by Specialty Chemicals, with guidance confirmed and expansions on track](https://longbridge.com/en/news/294338478.md)
- [AlzChem CEO Niedermaier reviews H1 2026 performance in Boersenradio interview](https://longbridge.com/en/news/294473127.md)
- [Renta 4 Banco insider-linked entity buys shares worth EUR 870.75](https://longbridge.com/en/news/294715946.md)
- [J.P. Morgan Reaffirms Their Buy Rating on SES S.A. (SES)](https://longbridge.com/en/news/294280273.md)